바이오프리저베이션 시장 : 업계 동향과 세계 예측 - 보존 상태별, 혈청 유형별, 생물학적 샘플 유형별, 응용 분야별, 포장 형태 유형별, 최종사용자별, 지역별

Biopreservation Market: Industry Trends and Global Forecasts - Distribution by Preservation Condition, Type of Serum, Type of Biological Sample, Area of Application, Type of Packaging Format, End Users, and Geographical Region :

US $ 4,799 ￦ 6,694,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,762,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,784,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,106,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 바이오프리저베이션 시장 : 개요

바이오프리저베이션 시장 규모는 2035년까지 예측 기간 동안 23.6%의 연평균 복합 성장률(CAGR)로 확대되어 현재 19억 달러에서 2035년까지 155억 달러로 성장할 것으로 예측됩니다.

시장 세분화에서는 시장 규모 및 기회 분석을 다음과 같은 매개 변수로 구분합니다.

보존 상태

• 냉장
• 냉동/콜드체인
• 냉동(초저냉동)/DeeAp 냉동
• 저온/LN2 기체상 보존

혈청 유형

• 소 태아 혈청 함유 배지
• 송아지 태아 혈청 함유 배지
• 인간 혈청 함유 배지
• 무혈청 배지

생물학적 샘플 유형

• 생식세포 및 줄기세포
• 장기
• 체세포
• 조직

응용 분야

• 진단
• 연구개발
• 치료

포장 형태 유형

• 백
• 보틀
• 바이알
• 기타

최종 사용자

• 학술연구기관
• 바이오뱅크 및 유전자 은행
• 병원
• 제약 및 바이오 기업
• 기타

지역

• 북미
• 유럽
• 아시아
• 중동 및 북아프리카
• 라틴아메리카
• 기타 지역

세계 바이오프리저베이션제 시장 : 성장과 트렌드

최근 효과적인 치료 솔루션에 대한 수요가 증가함에 따라 세포 기반 제품의 개발이 눈에 띄게 증가하고 있습니다. 미국 식품의약국(USFDA)의 조사에 따르면, 80% 이상의 간엽세포 기반 치료제 신청서에서 냉동보존의 필요성을 언급하고 있으며, 이는 유전체 무결성을 보호하고 스트레스에 의해 유발된 세포의 손상으로부터 세포를 보호할 수 있다는 것을 의미합니다. 이는 유전체과 단백질체학의 무결성을 보호하면서 스트레스에 의한 유전적 선택을 최소화할 수 있는 고도의 보존 전략이 시급히 필요함을 강조하고 있다(현재 대부분의 보존 방법으로는 불충분한 점이 있다).

바이오프리저베이션은 세포, 조직, 장기의 보존, 선적, 운송을 목적으로 세포, 조직, 장기를 생체 외에서 보존하기 위해 지정된 유일한 생물학적 접근법입니다. 또한, 바이오프리저베이션은 세포생물학 및 분자생물학의 비약적인 발전에 공학적 개념을 융합하여 제품과 관련된 다양한 문제에 대한 해결책을 제공합니다. 그 결과, 업계 이해관계자들은 이미 조제되어 시판되고 있는 바이오프리저베이션 배지에 점점 더 많은 관심을 기울이고 있습니다. 생물 보존 배지는 생물학적 시료의 보존에 있어 가장 중요한 요소 중 하나입니다. 배지의 유형 선택은 보존에 필요한 기간, 보존되는 생물학적 시료의 유형, 생물 보존의 목적에 따라 달라집니다. 현재 다양한 기업들이 다양한 유형의 생물학적 시료의 보존 및 보관을 위해 설계된 190개의 바이오프리저베이션 및 바이오뱅킹 솔루션을 제공합니다.

세계 바이오프리저베이션 시장 : 주요 인사이트

이 보고서는 세계 바이오프리저베이션 시장의 현황을 조사하고 업계 내 잠재적인 성장 기회를 파악합니다. 본 보고서의 주요 조사 결과는 다음과 같습니다.

• 전 세계적으로 60개 이상의 기업이 다양한 보존 상태의 생물학적 시료 보존을 위한 생물 보존 배지를 제공합니다.
• 바이오프리저베이션 배지는 다양한 생물 시료에 적합한 다양한 포장 형태 유형으로 제공되고 있습니다.
• 체세포 보존을 목적으로 하는 바이오프리저베이션 배지 중 약 45%는 혈청을 포함하지 않습니다.
• 바이오프리저베이션용 배지의 대부분(-90%)은 극저온 조건에서의 보존을 지원하며, 대표적인 예로는 C80EZ 2X, C80EZ Standard Medium, C80EZ-Neuron, C80EZ-TISSUE를 들 수 있습니다.
• 다양한 포장 형태로 배지를 제공하는 대표적인 기업으로는 Akron Biotech, BioLife Solutions, Fuji Film, Protide Pharmaceuticals, ScienCell Research Laboratories 등을 들 수 있습니다.
• 경쟁 우위를 구축하기 위해 기업은 제공하는 매체의 특성을 꾸준히 개선하는 데 주력하고 있습니다.

• 이해관계자들의 관심이 높아진 것은 제휴 활동의 활성화에서도 알 수 있습니다.
• 기존 기업도 신규 진출기업도 최근 몇 개의 파트너십을 체결하고 있습니다.
• 하지만 중장기적으로는 유명 학술기관과도 협약을 맺을 것으로 예측됩니다.
• 비용은 이러한 바이오프리저베이션 배지의 수용과 채택의 중요한 결정 요인입니다. 가격 전략 매트릭스는 진입기업이 자사 제품의 경쟁 시장 가격을 평가할 때 유용하게 활용될 수 있습니다.
• 온도에 민감한 제품의 승인 증가에 힘입어 바이오프리저베이션 매체 제공업체 시장은 2035년까지 연평균 23.6% 이상 성장할 것으로 예측됩니다.

• 예측된 시장 기회는 다양한 최종 사용자, 생물학적 샘플, 포장 형태 유형, 주요 지리적 지역으로 잘 분산될 것으로 보입니다.

바이오 프리저베이션 시장 진출기업 사례

• BioLife Solutions
• Cell Applications
• HiMedia Laboratories
• Merck
• Thermo Fisher Scientific
• United States Biological
• ZenBio

세계의 바이오프리저베이션(Biopreservation) 시장에 대해 조사했으며, 시장 개요와 함께 보존 상태별, 혈청 유형별, 생물학적 샘플 유형별, 응용 분야별, 포장 형태별, 최종사용자별 동향, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다. 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 주요 요약

제3장 서론

• 본 장의 개요
• 바이오프리저베이션 도입
• 바이오프리저베이션의 유형
• 바이오프리저베이션 매체 응용
• 바이오프리저베이션 배지의 장점과 한계
• 결론

제4장 시장 구도

• 본 장의 개요
• 바이오프리저베이션 배지 프로바이더 : 서비스 제공업체 상황
• 바이오프리저베이션 배지 : 시장 구도

제5장 주요 인사이트

제6장 기업 경쟁력

• 본 장의 개요
• 전제와 주요 파라미터
• 조사 방법
• 제품 포트폴리오 힘 벤치마크
• 파트너십 활동 벤치마킹
• 바이오프리저베이션 배지 프로바이더 : 기업 경쟁력 분석

제7장 기업 개요

• 본 장의 개요
• BioLife Solutions
• Cell Applications
• HiMedia Laboratories
• Merck
• Thermo Fischer Scientific
• United States Biological
• ZenBio

제8장 파트너십 및 협업

• 본 장의 개요
• 파트너십 모델
• 바이오프리저베이션 배지 프로바이더 : 파트너십 및 협업

제9장 보우만크로크 가격 전략

제10장 시장 규모 평가와 기회 분석

• 본 장의 개요
• 예측 조사 방법과 주요 전제조건
• 바이오프리저베이션 배지 프로바이더 시장, -2035년
• 바이오프리저베이션 배지 프로바이더 시장 : 보존 상태 별
• 바이오프리저베이션 배지 프로바이더 시장 : 혈청 유형별
• 바이오프리저베이션 매체 프로바이더 시장 : 생물학적 샘플 유형별
• 바이오프리저베이션 배지 프로바이더 시장 : 응용 분야별
• 바이오프리저베이션 배지 프로바이더 시장 : 포장 형태 유형별
• 바이오프리저베이션 배지 프로바이더 시장 : 최종사용자별
• 바이오프리저베이션 배지 프로바이더 시장 : 지역별
• 결론

제11장 결론

제12장 경영진 인사이트

제13장 부록 I : 표 형식 데이터

제14장 부록 II : 기업 및 조직 리스트

LSH

영문 목차

영문목차

GLOBAL BIOPRESERVATION MARKET: OVERVIEW

As per Roots Analysis, the biopreservation market is estimated to grow from USD 1.9 billion in the current year to USD 15.5 billion by 2035, at a CAGR of 23.6% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Preservation Condition

• Refrigerated
• Frozen / Cold Chain
• Frozen (Ultra-low) / DeeAp Frozen
• Cryogenic / LN2 Vapor Phase Storage

Type of Serum

• Fetal Bovine Serum Containing Media
• Fetal Calf Serum Containing Media
• Human Serum Containing Media
• Serum Free Media

Type of Biological Sample

• Germline Cells / Stem Cells
• Organs
• Somatic Cells
• Tissues

Area of Application

• Diagnostic Use
• Research and Development
• Therapeutic Use

Type of Packaging Format

• Bags
• Bottles
• Vials
• Others

End Users

• Academic and Research Institutes
• Biobanks / Genebanks
• Hospitals
• Pharmaceutical and Biotechnology Companies
• Other End Users

Geographical Region

• North America
• Europe
• Asia
• Middle East and North Africa
• Latin America
• Rest of the World

GLOBAL BIOPRESERVATION MARKET: GROWTH AND TRENDS

In recent years, there has been a noticeable increase in the development of cell-based products, driven by the rising demand for effective therapeutic solutions. However, these products are highly sensitive to temperature fluctuations and often require freezing or cryogenic conditions for safe transport and storage. According to a study by the USFDA, over 80% of submissions for mesenchymal cell-based therapies indicated a need for cryopreservation. This highlights the urgent need for advanced preservation strategies that can safeguard both genomic and proteomic integrity, while minimizing stress-induced genetic selection (an aspect where most current preservation methods fall short).

Biopreservation is the exclusive biological approach designated for the preservation of cells, tissues and organs ex-vivo for the purpose of storage, shipment and transportation. Further, biopreservation offers solutions to various product-related challenges by integrating engineering concepts with breakthroughs in cellular and molecular biology. Consequently, industry stakeholders are increasingly turning to pre-formulated, commercially available biopreservation media. Biopreservation media is one of the most crucial entities in conferring effectiveness in preservation of biological samples. The selection of the type of media depends upon the considerable time duration desired for the storage, type of biological material to be preserved and the purpose of biopreservation. Currently, various companies are engaged in providing 190 biopreservation and biobanking solutions designed for the storage and preservation of various types of biological samples.

GLOBAL BIOPRESERVATION MARKET: KEY INSIGHTS

The report delves into the current state of global biopreservation market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Globally, over 60 companies provide biopreservation media, intended for the preservation of biological samples at different preservation conditions.
• Biopreservation media is available in different packaging formats that are compatible with a variety of biological samples.
• Amongst the biopreservation media intended for preservation of somatic cells, nearly 45% are serum free; of these, majority are being used for storage at cryogenic conditions.
• Largely, the biopreservation media support preservation at cryogenic conditions (~90%), prominent examples include C80EZ 2X, C80EZ Standard Medium, C80EZ-Neuron, and C80EZ-TISSUE.
• Prominent examples of companies offering media in multiple packaging formats include Akron Biotech, BioLife Solutions, Fujifilm, Protide Pharmaceuticals, and ScienCell Research Laboratories.
• In order to build a competitive advantage, companies are focused on steadily improving the characteristics of their media offerings.

• The growing interest of stakeholders is also evident from the rise in partnership activity; a relatively larger proportion of the deals were signed by companies based in the US.
• Both established players and new entrants have signed several partnerships in the recent past; most of the companies (~45%) are actively signing manufacturing and supply agreements.
• Industry players have emerged as preferred choice of partner for companies of variable employee strength; however, in mid-to-long term, we expect firms to ink agreements with renowned academic institutes as well.
• Cost is a key determinant of the acceptance and adoption of such biopreservation media; pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their offerings.
• Driven by the rising approval of temperature sensitive products, the market for biopreservation media providers is poised to grow at an annualized rate of over 23.6%, till 2035.

• The projected market opportunity is likely to be well distributed across different end users, biological samples, packaging formats and key geographical regions.

Example Players in the Biopreservation Market

• BioLife Solutions
• Cell Applications
• HiMedia Laboratories
• Merck
• Thermo Fisher Scientific
• United States Biological
• ZenBio

GLOBAL BIOPRESERVATION MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global biopreservation market, focusing on key market segments, including [A] preservation condition, [B] type of serum, [C] type of biological sample, [D] area of application, [E] type of packaging format, [F] end users and [E] geographical regions.
• Market Landscape: A comprehensive evaluation of the current biopreservation media providers' landscape, considering various parameters, such as [A] year of establishment, [B] company size, [C] type of company and [D] location of headquarters. Additionally, a comprehensive evaluation of biopreservation media based on several relevant parameters, such as [A] preservation condition, [B] type of serum, [C] type of biological sample, [D] area of application, [E] type of packaging format, [F] packaging volume and [G] product price.
• Key Insights: In-depth analysis of market trends, focusing on location of headquarters and leading players engaged in offering biopreservation media based on the parameters, such as [A] year of establishment, [B] company size, [C] number of biopreservation media offered and [D] region. Further, an insightful representation of biopreservation media, distributed based on [A] preservation condition and [B] area of application, a grid representation illustrating the distribution of biopreservation media based on [A] company size, [B] region, preservation condition, [C] type of serum and type of biological sample, and a heat map representation of biopreservation media, distributed on the basis of [A] minimum packaging volume and [B] minimum price.
• Company Competitiveness Analysis: A comprehensive competitive analysis of biopreservation media providers, examining factors, such as [A] years of experience, [B] product portfolio strength and [C] partnership activity.
• Company Profiles: In-depth profiles of companies engaged in this domain, focusing on [A] company overview, and [B] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the biopreservation market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] most active players (in terms of the number of partnerships signed) and [E] geography.
• Bowman Clock Pricing Strategy: In-depth analysis of a framework to understand the pricing strategy of the biopreservation media provided by the company along with its competitive position.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

• 2.1. Chapter Overview

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Introduction to Biopreservation
• 3.3. Type of Biopreservation
  • 3.3.1. Hypothermic Preservation
  • 3.3.2. Cryopreservation
• 3.4. Applications of Biopreservation Media
• 3.5. Benefits and Limitations of Biopreservation Media
• 3.6. Concluding Remarks

4. MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Biopreservation Media Providers: Service Providers Landscape
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Type of Company
  • 4.2.4. Analysis by Location of Headquarters
• 4.3. Biopreservation Media: Market Landscape
  • 4.3.1. Analysis by Preservation Condition
  • 4.3.2. Analysis by Type of Serum
  • 4.3.3. Analysis by Type of Biological Sample
  • 4.3.4. Analysis by Area of Application
  • 4.3.5. Analysis by Type of Packaging Format
  • 4.3.6. Analysis by Packaging Volume
  • 4.3.7. Analysis by Product Price

5. KEY INSIGHTS

• 5.1. Chapter Overview
• 5.2. Analysis by Location of Headquarters (World Map Representation)
• 5.3. Analysis by Year of Establishment, Company Size, Number of Biopreservation Media Offered and Region (4D Bubble Chart)
• 5.4. Analysis by Preservation Condition and Area of Application (Treemap Representation)
• 5.5. Analysis by Company Size, Region, Preservation Condition, Type of Serum and Type of Biological Sample (Grid Representation)
• 5.6. Analysis by Minimum Packaging Volume and Minimum Price (Heat Map Representation)

6. COMPANY COMPETITIVENESS

• 6.1. Chapter Overview
• 6.2. Assumptions and Key Parameters
• 6.3. Methodology
• 6.4. Benchmarking of Product Portfolio Strength
• 6.5. Benchmarking of Partnership Activity
• 6.6. Biopreservation Media Providers: Company Competitiveness Analysis
  • 6.6.1. Company Competitiveness Analysis: Very Small Companies
  • 6.6.2. Company Competitiveness Analysis: Small Companies
  • 6.6.3. Company Competitiveness Analysis: Mid-Sized Companies
  • 6.6.4. Company Competitiveness Analysis: Large Companies

7. COMPANY PROFILES

• 7.1. Chapter Overview
• 7.2. BioLife Solutions
  • 7.2.1. Company Overview
  • 7.2.2. Recent Developments and Future Outlook
• 7.3. Cell Applications
  • 7.3.1. Company Overview
  • 7.3.2. Recent Developments and Future Outlook
• 7.4. HiMedia Laboratories
  • 7.4.1. Company Overview
  • 7.4.2. Recent Developments and Future Outlook
• 7.5. Merck
  • 7.5.1. Company Overview
  • 7.5.2. Recent Developments and Future Outlook
• 7.6. Thermo Fischer Scientific
  • 7.6.1. Company Overview
  • 7.6.2. Recent Developments and Future Outlook
• 7.7. United States Biological
  • 7.7.1. Company Overview
  • 7.7.2. Recent Developments and Future Outlook
• 7.8. ZenBio
  • 7.8.1. Company Overview
  • 7.8.2. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS

• 8.1. Chapter Overview
• 8.2. Partnership Models
• 8.3. Biopreservation Media Providers: Partnerships and Collaborations
  • 8.3.1. Analysis by Year of Partnership
  • 8.3.2. Analysis by Type of Partnership
    • 8.3.2.1. Analysis by Year and Type of Partnership
    • 8.3.2.2. Analysis by Type of Partnership and Company Size
  • 8.3.3. Analysis by Type of Partner
    • 8.3.3.1. Analysis by Year of Partnership and Type of Partner
    • 8.3.3.2. Analysis by Type of Partner and Type of Partnership
    • 8.3.3.3. Analysis by Type of Partner and Company Size
  • 8.3.4. Most Active Players: Analysis by Number of Partnerships
  • 8.3.5. Regional Analysis
    • 8.3.5.1. Local and International Deals
    • 8.3.5.2. Intercontinental and Intracontinental Deals
    • 8.3.5.3. Analysis by Location of Headquarters of Partner
    • 8.3.5.4. Analysis by Location of Headquarters of Partner and Type of Partnership

9. BOWMAN CLOCK PRICING STRATEGY

• 9.1. Chapter Overview
• 9.2. Bowman Strategy Clock
  • 9.2.1. Two Dimensions of Bowman Strategy Clock
  • 9.2.2. Eight Positions on Bowman Strategy Clock
• 9.3. Roots Analysis Framework
  • 9.3.1. Methodology
  • 9.3.2. Theoretical Framework and Price Evaluation Hypothesis
  • 9.3.3. Results and Interpretation
    • 9.3.3.1. Product Price Evaluation Matrix: Information on Preservation Condition
    • 9.3.3.2. Product Price Evaluation Matrix: Information on Type of Serum
    • 9.3.3.3. Product Price Evaluation Matrix: Information on Type of Biological Sample
    • 9.3.3.4. Product Price Evaluation Matrix: Information on Minimum Packaging Volume
    • 9.3.3.5. Product Price Evaluation Matrix: Information on Maximum Packaging Volume
    • 9.3.3.6. Product Price Evaluation Matrix: Information on Packaging Format
    • 9.3.3.7. Product Price Evaluation Matrix: Information on Area of Application
  • 9.3.4. Concluding Remarks

10. MARKET SIZING AND OPPORTUNITY ANALYSIS

• 10.1. Chapter Overview
• 10.2. Forecast Methodology and Key Assumptions
• 10.3. Biopreservation Media Providers Market, Till 2035
• 10.4. Biopreservation Media Providers Market: Distribution by Preservation Condition
  • 10.4.1. Biopreservation Media Providers Market for Cryogenic / LN2 Vapor Phase, Till 2035
  • 10.4.2. Biopreservation Media Providers Market for Frozen (Ultra-low) / Deep Frozen, Till 2035
  • 10.4.3. Biopreservation Media Providers Market for Frozen / Cold Chain, Till 2035
  • 10.4.4. Biopreservation Media Providers Market for Refrigerated, Till 2035
• 10.5. Biopreservation Media Providers Market: Distribution by Type of Serum
  • 10.5.1. Biopreservation Media Providers Market for Fetal Bovine Serum Containing Media, Till 2035
  • 10.5.2. Biopreservation Media Providers Market for Fetal Calf Serum Containing Media, Till 2035
  • 10.5.3. Biopreservation Media Providers Market for Human Serum Containing Media, Till 2035
  • 10.5.4. Biopreservation Media Providers Market for Serum Free Media, Till 2035
• 10.6. Biopreservation Media Providers Market: Distribution by Type of Biological Sample
  • 10.6.1. Biopreservation Media Providers Market for Germline Cells / Stem Cells, Till 2035
  • 10.6.2. Biopreservation Media Providers Market for Organs, Till 2035
  • 10.6.3. Biopreservation Media Providers Market for Somatic Cells, Till 2035
  • 10.6.4. Biopreservation Media Providers Market for Tissues, Till 2035
• 10.7. Biopreservation Media Providers Market: Distribution by Area of Application
  • 10.7.1. Biopreservation Media Providers Market for Diagnostic Use, Till 2035
  • 10.7.2. Biopreservation Media Providers Market for Research and Development, Till 2035
  • 10.7.3. Biopreservation Media Providers Market for Therapeutic Use, Till 2035
• 10.8. Biopreservation Media Providers Market: Distribution by Type of Packaging Format
  • 10.8.1. Biopreservation Media Providers Market for Bags, Till 2035
  • 10.8.2. Biopreservation Media Providers Market for Bottles, Till 2035
  • 10.8.3. Biopreservation Media Providers Market for Vials, Till 2035
  • 10.8.4. Biopreservation Media Providers Market for Others, Till 2035
• 10.9. Biopreservation Media Providers Market: Distribution by End Users
  • 10.9.1. Biopreservation Media Providers Market for Academic and Research Institutes, Till 2035
  • 10.9.2. Biopreservation Media Providers Market for Biobanks / Genebanks, Till 2035
  • 10.9.3. Biopreservation Media Providers Market for Hospitals, Till 2035
  • 10.9.4. Biopreservation Media Providers Market for Pharmaceutical and Biotechnology Companies, Till 2035
  • 10.9.5. Biopreservation Media Providers Market for Other End Users, Till 2035
• 10.10. Biopreservation Media Providers Market: Distribution by Region
  • 10.10.1. Biopreservation Media Providers Market in North America, Till 2035
  • 10.10.2. Biopreservation Media Providers Market in Europe, Till 2035
  • 10.10.3. Biopreservation Media Providers Market in Asia, Till 2035
  • 10.10.4. Biopreservation Media Providers Market in MENA, Till 2035
  • 10.10.5. Biopreservation Media Providers Market in Latin America, Till 2035
  • 10.10.6. Biopreservation Media Providers Market in Rest of the World, Till 2035
• 10.11. Concluding Remarks

11. CONCLUSION

• 11.1. Chapter Overview

12. EXECUTIVE INSIGHTS

• 12.1. Chapter Overview
• 12.2. Company A
  • 12.2.1. Company Snapshot
  • 12.2.2. Interview Transcript: Marketing Director

13. APPENDIX I: TABULATED DATA

14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

관련자료